Posts by: Joana Carvalho

News

Scientists have created a new artificial intelligence (AI)-based model that outperforms current models at predicting the risks a woman has of developing breast cancer, and works equally well in ... Read more

May 31, 2019May 31, 2019

Prestige’s HD201, a Biosimilar to Herceptin, Accepted for Review in Europe for HER2-positive BC

News

The European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) submitted by Prestige BioPharma for HD201, its lead biosimilar to Genentech‘s Herceptin (trastuzumab). Like Herceptin, ... Read more

May 24, 2019

Keytruda Fails to Improve Overall Survival of Patients with Triple-Negative Breast Cancer, Phase 3 Trial Shows

News

Keytruda (pembrolizumab), Merck‘s anti-PD-1 checkpoint blockade immunotherapy, failed to prolong the overall survival of patients with metastatic triple-negative breast cancer (TNBC) beyond that provided by chemotherapy agents, a Phase ... Read more

May 22, 2019

Treatment Intensity Should Be Personalized in Women with HER2-positive Breast Cancer, Study Says

News

Personalized treatment intensity is crucial to the success of less toxic and demanding therapies for women with HER2-positive breast cancer, according to a spokesperson from the European Society for ... Read more

May 20, 2019

Young Women More Likely to Face Aggressive BC Types, But Proper Treatment Improves Outcomes

News

Young women are more likely than older ones to be diagnosed with more aggressive forms of breast cancer, but their outcomes can be good if they follow recommended treatments. ... Read more

May 15, 2019

Experimental Antibody Therapy Leads to Significant Responses in HER2-positive Breast Cancer, Phase 2 Trial Shows

News

Trastuzumab deruxtecan (DS-8201), an investigational antibody-drug conjugate developed by AstraZeneca with Daiicho Sankyo, led to clinically meaningful responses in patients with advanced HER2-positive breast cancer, a Phase 2 clinical ... Read more

May 3, 2019

New Imaging Tool Captures Process That Turns Tumor Cells Malignant in Breast Cancer

News

A new imaging technique that visualizes individual cells with high resolution may improve the understanding of key events in breast cancer development, including how and when cells turn invasive and ... Read more

April 12, 2019

Surgery Extends Lives of Women with Metastatic Breast Cancer, Study Says

News

Women with HER2-positive breast cancer that has spread to distant organs live longer if they have surgery to remove their primary tumor, according to research presented at the recent ... Read more

April 3, 2019

FDA Proposes New Policies to Modernize, Improve Quality of Mammography Screenings

News

The U.S. Food and Drug Administration (FDA) has proposed a set of new policies to modernize and improve the quality of mammography screenings for breast cancer. The federal agency ... Read more

April 1, 2019

Breast Cancer Survivors Weigh in on Ways to Reduce the Financial Burden of the Disease

News

A qualitative study has proposed nine recommendations from breast cancer survivors about how to reduce the financial burden associated with the disease, which include changes to insurance, supportive services, ... Read more

Posts by: Joana Carvalho

Joana Carvalho

New AI-based Model Outperforms Current Methods of Predicting Breast Cancer Risk

Prestige’s HD201, a Biosimilar to Herceptin, Accepted for Review in Europe for HER2-positive BC

Keytruda Fails to Improve Overall Survival of Patients with Triple-Negative Breast Cancer, Phase 3 Trial Shows

Treatment Intensity Should Be Personalized in Women with HER2-positive Breast Cancer, Study Says

Young Women More Likely to Face Aggressive BC Types, But Proper Treatment Improves Outcomes

Experimental Antibody Therapy Leads to Significant Responses in HER2-positive Breast Cancer, Phase 2 Trial Shows

New Imaging Tool Captures Process That Turns Tumor Cells Malignant in Breast Cancer

Surgery Extends Lives of Women with Metastatic Breast Cancer, Study Says

FDA Proposes New Policies to Modernize, Improve Quality of Mammography Screenings

Breast Cancer Survivors Weigh in on Ways to Reduce the Financial Burden of the Disease

Pin It on Pinterest